1 / 14

Europe Biopsy Devices Market, Size, Forecast 2022-2027

According to Renub Research, Europe Biopsy Devices Market will reach US$ 996.3 Million in 2027. A biopsy is a medical operation that removes tissues or cells from the organs to aid in examining disorders. Surgeons, radiologists, cardiologists, and other medical professionals undertake the procedure using biopsy devices. These devices are made to remove diagnostic-quality specimens while minimizing crush artifacts and tissue fragmentation. Biopsy guiding systems, needle-based biopsy guns, biopsy needles, and biopsy forceps are the most often used biopsy instruments.

renubresearch
Download Presentation

Europe Biopsy Devices Market, Size, Forecast 2022-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Europe Biopsy Devices Market According to Renub Research, Europe Biopsy Devices Market will reach US$ 996.3 Million in 2027. A biopsy is a medical operation that removes tissues or cells from the organs to aid in examining disorders. Surgeons, radiologists, cardiologists, and other medical professionals undertake the procedure using biopsy devices. These devices are made to remove diagnostic-quality specimens while minimizing crush artifacts and tissue fragmentation. Biopsy guiding systems, needle-based biopsy guns, biopsy needles, and biopsy forceps are the most often used biopsy instruments. They are being used in a wide range of healthcare settings throughout Europe, including medical clinics, diagnostic facilities, and hospitals. Europe Biopsy Devices Market Size is likely to expand at a CAGR of 6.90% during 2021 – 2027: Increased investments in R&D activities are driving the Europe Biopsy Devices Market. For example, the European Union's Horizon 2020 initiative awarded €6.3 million for MRI research and liquid biopsy research. Furthermore, increased public awareness regarding biopsy procedures and screening tests contributes to the region's market growth. Moreover, healthcare professionals concentrate on minimally invasive (MI) biopsy technologies, expected to boost the market growth. Europe Biopsy Devices Market

  2. Europe Biopsy Devices Market Europe Biopsy Devices Market 2021 – 2027 Europe Biopsy Devices Market

  3. Europe Biopsy Devices Market Needle-based Biopsy Instruments are Expected to Hold a Major Market Share: By Product, needle-based biopsy has the largest market share due to the rising demand for equipment for obtaining samples from soft tissues of internal organs such as the breasts, kidneys, and lungs. Hence, the factor above is expected to contribute to the overall market's growth during the projected period. Furthermore, the growing demand for Fine Aspiration Needles and Core Needles for obtaining samples from soft tissues of internal organs, including the breasts, prostate, and lungs, is propelling the market forward. By Imaging Technology, CT scan, Stereotactic Guided, Ultrasound Guided, and MRI Guided are all utilized extensively in treating breast cancer, lung cancer, and prostate cancer across a wide range of end-users, including diagnostic centers and hospitals. Furthermore, enhanced healthcare infrastructure and the rising occurrence of infections have boosted the growth of biopsy instruments over the forecast period. This is due to the expansion of the healthcare sector in emerging economies, increased out-of-pocket healthcare spending, and the number of hospitals. Europe Biopsy Devices Market

  4. Europe Biopsy Devices Market Regional Analysis – Germany is the leading contributor to the Europe Biopsy Devices Industry: In Europe, Germany is the top contributor to the biopsy device market. It's because of the high number of qualified medical experts, well-developed infrastructure, and the presence of the majority of essential stakeholders. Furthermore, France is an attractive site for medical device producers. The rapid improvement of healthcare infrastructure in emerging France, combined with high unmet patient requirements and rising breast cancer incidence, is expected to boost demand for biopsy devices. Competitive Landscape: The Biopsy Devices Market in Europe is very competitive. Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Exact Sciences (Genomic Health), Biocept, Biocartis, Roche Diagnostics, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories, and Quest Diagnostics Inc. are the leading market competitors in the biopsy devices industry. Europe Biopsy Devices Market

  5. Europe Biopsy Devices Market To benefit the sector, these companies are pursuing methods such as product introduction through technological advancements and alliances. New product launches are the most favored strategy for market capitalization, followed by collaborations and geographic expansion. How COVID-19 Affected the Europe Biopsy Devices Industry: The Coronavirus outbreak damaged the European biopsy diagnostics centers, hospitals, supply chains, and clinical trials. Cancer diagnoses were being delayed since diagnosis services and screening programs had been halted since the beginning of the COVID-19 outbreak. Cancer patients had numerous obstacles outside of the pandemic, including increased susceptibility to severe infection and disruptions in treatment or routine medical care. According to our analysis, the Europe Biopsy Devices Market was negatively impacted from the end of 2019 to the beginning of 2020. According to our estimates, Europe Biopsy Devices Market reached US$ 667.6 Billion in 2021 post recovery from the pandemic scenario. Request a free sample copy of the report: https://www.renub.com/request- sample-page.php?gturl=europe-biopsy-devices-market-p.php Europe Biopsy Devices Market

  6. Europe Biopsy Devices Market Renub Research latest report “Europe Biopsy Devices Market, Forecast By Product (Needle Based, Biopsy Forceps, Localization Wire, Others), Imaging Technology (CT scan, Stereotactic Guided, Ultrasound Guided, MRI Guided and Others), Country (United Kingdom, France, Germany, Italy, Spain, Russia and Rest of Europe), End-User (Diagnostic Centers, Hospitals and Others), Application (Cancer Type) (Breast Cancer, Lung Cancer, Prostate Cancer and Others), Companies (Becton, Dickinson and Company, Thermo Laboratories, Exact Sciences (Genomic Diagnostics, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories, and Quest Diagnostics Inc.)” provides a detailed analysis of Europe Biopsy Devices Industry. Fisher Scientific Biocept, Inc, Bio-Rad Roche Health), Biocartis, Request a free Brochure copy of the report: https://www.renub.com/request- brochure-page.php?gturl=europe-biopsy-devices-market-p.php Europe Biopsy Devices Market

  7. Europe Biopsy Devices Market Forecast for Europe Biopsy Devices Market Share (%) - by Countries (2022 - 2027) Europe Biopsy Devices Market

  8. Europe Biopsy Devices Market Product - The market has been studied from 4 viewpoints: 1. Needle Based 2. Biopsy Forceps 3. Localization Wire 4. Others Imaging Technology - The market has been studied from 5 viewpoints: 1. CT scan 2. Stereotactic Guided 3. Ultrasound Guided 4. MRI Guided 5. Others Europe Biopsy Devices Market

  9. Europe Biopsy Devices Market Country - The market has been studied from 7 viewpoints: United Kingdom France Germany Italy Spain Russia Rest of Europe End-User - The market has been studied from 3 viewpoints: Diagnostic Centers Hospitals Others Europe Biopsy Devices Market

  10. Europe Biopsy Devices Market Application (Cancer Type) - The market has been studied from 4 viewpoints: 1. Breast Cancer 2. Lung Cancer 3. Prostate Cancer 4. Others Company Insights: Overview Initiatives/Recent Developments Financial Insight • • • Europe Biopsy Devices Market

  11. Europe Biopsy Devices Market Companies Covered: 1. Becton, Dickinson and Company 2. Thermo Fisher Scientific Inc 3. Bio-Rad Laboratories 4. Exact Sciences (Genomic Health) 5. Biocept 6. Biocartis 7. Roche Diagnostics 8. Myriad Genetics Inc. 9. Qiagen 10.NeoGenomics Laboratories 11.Quest Diagnostics Inc. Europe Biopsy Devices Market

  12. Europe Biopsy Devices Market Europe Biopsy Devices Market

  13. Europe Biopsy Devices Market Biopsy Devices Market Global Forecast 2021-2027, Impact of COVID-19, Size, Share, Insight, Growth, Opportunity Company Analysis Liquid Biopsy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis Transdermal Skin Patches Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis Transcatheter Heart Valve Replacement Market, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Company Analysis Europe Biopsy Devices Market

  14. Contact Us +1-678-302-0700 (US), +91-120-421-9822 (INDIA) https://www.renub.com Stay with us: Stay with us: Europe Biopsy Devices Market

More Related